SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against The Allstate Corporation (ALL) & Lead Plaintiff Deadline: January 10, 2017

NEW YORK, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against The Allstate Corporation ("Allstate" or the “Company”) (NYSE: ALL ) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Allstate between October 30, 2014 and August 3, 2015, both dates inclusive (the "Class Period").

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).  

Allstate is the largest publicly traded personal lines insurance company in the United States. Allstate was founded in 1931 as part of Sears, Roebuck and Co., and was spun off in 1993. The company has had its headquarters in Northfield Township, Illinois, near Northbrook since 1967.

The complaint alleges that throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose adverse information about its business and prospects. Specifically, the complaint alleges that Defendants omitted information about the sudden spike in its auto claims frequency, that defendants attributed to external events beyond its control, including weather and increased miles driven as factors, when actually the result of Allstate's auto policy growth was due to higher risk drivers.  As an outcome of the Company’s false statements and/or omissions, Allstate stock traded at artificially inflated prices during the Class Period, reaching a high of $72.58 per share. During this time, some Company insiders, including its CEO, sold their Allstate shares at artificially inflated prices.

On August 3, 2015, post-market, Allstate revealed its discouraging 2015 second quarter financial results. This was Allstate’s third consecutive quarter of increased auto claims frequency, and also listed a 57% drop in operating income, and operating earnings per share that were $0.34 below analysts' projections.  Following Allstate’s release, the CEO said that its lower quarterly profit was "driven by a deterioration in auto insurance margins" and continued to say that "[a]uto insurance margins decreased as higher claim frequency and severity more than offset average auto insurance price increases."  Following these releases, Allstate stock dropped $7.04 per share and closed at $62.34 per share on August 4, 2015.

No Class has yet been certified in the above action.  To discuss this action, or for any questions, please visit the firm’s site: http://www.bgandg.com/all or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com . Those who inquire by e-mail are encouraged to include their mailing address and telephone number.  If you suffered a loss in Allstate, you have until January 10, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 61

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Tigermed's Strategic Shift: Privatization and Divestment

Updated Category News Views 28

Hang onto your hats, folks, because Tigermed is shaking things up in a big way. The Chinese juggernaut you might know as Hangzhou Tigermed Consulting Co., Ltd. is throwing its hat in the ring for the privatization of Frontage Holdings. But that's not the end of the story—there's a whole restructuring circus coming to town, and they've got big plans to offload some...

Continue Reading
RLX Technology Gears Up for Q3 Earnings Call Ahead

Updated Category News Views 13

Under the Microscope: RLX Q3 2026 Earnings Get ready, because November 20 is shaping up to be a real event for RLX Technology watchers. The e-vapor heavyweight is gonna drop its Q3 results right before the crack of dawn U.S. markets open. Now, that's a time that stirs more coffee pots than debates—at 7:00 AM Eastern Time, to be precise. So, you better be braced for some...

Continue Reading
Electra Defense's $4.7M Contract Fuels USAF Innovation

Updated Category News Views 119

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Continue Reading
Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 103

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
CeQur Revolutionizes Insulin Delivery with Wearable Patch

Updated Category News Views 11

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Continue Reading
Cepheid Expands Diagnostic Potential with IVDR Approval

Updated Category News Views 25

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

Continue Reading
SOTERIA and Tempus Unite for Military Cancer Battle

Updated Category News Views 115

The Military Faces Cancer's Grasp: A New Frontline There's a battle brewing in the healthcare world, one distinctly different from the chaos of stock tickers or quarterly earnings. It's about saving lives in a space where tactical precision is everything—cancer care for U.S. military personnel and veterans. SOTERIA Precision Medicine Foundation and Tempus (NASDAQ: TEM)...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 82

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Trimble's New Machine Control Tech Promises Big Gains

Updated Category News Views 50

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...

Continue Reading

Top 5 Most Recently Viewed Articles

PENN Entertainment Partners with Monumental Sports for ESPN BET

Updated Category News Views 163

PENN Entertainment Forms Alliance with Monumental Sports PENN Entertainment, Inc. (NASDAQ:PENN) has reached a significant agreement with Monumental Sports & Entertainment to establish a long-term partnership that focuses on enhancing sports betting experiences in Washington D.C. This collaboration secures PENN access to the online market for its ESPN BET platform, pending...

Continue Reading
Sentral Expands Multifamily Management Ventures in Texas and Bay Area

Updated Category News Views 554

Sentral Expands Its Reach in the Multifamily Sector Sentral, a top-tier Class A multifamily management company, is on a growth path as it announces its latest contracts that strengthen its presence in two major markets. The company is adding three new properties to its extensive portfolio, including a groundbreaking development in Houston and two additional properties in...

Continue Reading
Anticipated IPO Surge in 2025 Promises Exciting Deals Ahead

Updated Category News Views 247

Anticipating a Surge in IPOs for 2025 Investment bankers are gearing up for an exciting year in the equity capital markets. As we look ahead, there's a sense of optimism about new initial public offerings (IPOs) that could shape the financial landscape. This anticipation is fueled by a promising pipeline of well-known companies poised to enter the stock market. Key...

Continue Reading
Erika Kirk Introduces Book and Shares Her Journey on FOX News

Updated Category News Views 249

Erika Kirk's Book Tour Launch on FOX News During an exciting week of interviews on FOX News Media, Erika Kirk will unveil her new book tour for her late husband Charlie Kirk's work titled "STOP, in the Name of God: Why Honoring the Sabbath Will Transform Your Life." This series of interviews will commence on the week of December 8th, featuring discussions that delve into...

Continue Reading
Nutrien and Mosaic Stocks Surge Following Potash Production Cuts

Updated Category News Views 243

Nutrien and Mosaic Experience Stock Price Increases Shares of Nutrien Ltd (NYSE: NTR) have climbed impressively by 3.6%, while Mosaic Co (NYSE: MOS) enjoyed a robust increase of 4.8%. This positive momentum coincides with significant news of a production cut from Belarusian potash supplier Belaruskali. The company's decision to reduce potash production is a strategic move...

Continue Reading